M1 macrophages promote beneficial anti-tumor effects by driving the Th1 response and via the secretion of TNF-α, IL-1, IL-6, IL-12, Type I IFN, CXCL1-3, CXCL5, and CXCL8-10. Here, CXCL5 is linked to neoplasm.